Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman View more
Aldevron, Nature Technology Corporation Team Up to Offer Nanoplasmids™ for Gene Therapy Manufacturing View more
EQT to Acquire Majority Interest in Aldevron – the Leading Global Supplier of Plasmid DNA Used in Cell and Gene Therapies View more